QiDongNing induces lung cancer cell apoptosis via triggering P53/DRP1-mediated mitochondrial fission

Non-small-cell lung Cancer (NSCLC) is a major cause of worldwide Cancer death, posing a challenge for effective treatment. Our previous findings showed that Chinese herbal medicine (CHM) QiDongNing (QDN) could upregulate the expression of p53 and trigger cell Apoptosis in NSCLC. Here, our objective was to investigate the mechanisms of QDN-induced Apoptosis enhancement. We chose A549 and NCI-H460 cells for validation in vitro, and LLC cells were applied to form a subcutaneous transplantation tumour model for validation in more depth. Our findings indicated that QDN inhibited multiple biological behaviours, including cell proliferation, cloning, migration, invasion and induction of Apoptosis. We further discovered that QDN increased the pro-apoptotic Bax while inhibiting the anti-apoptotic Bcl2. QDN therapy led to a decline in adenosine triphosphate (ATP) and a rise in Reactive Oxygen Species (ROS). Furthermore, QDN elevated the levels of the tumour suppressor p53 and the mitochondrial division factor DRP1 and FIS1, and decreased the mitochondrial fusion molecules MFN1, MFN2, and OPA1. The results were further verified by rescue experiments, the p53 inhibitor Pifithrin-α and the mitochondrial division inhibitor Mdivi1 partially inhibited QDN-induced Apoptosis and mitochondrial dysfunction, whereas overexpression of p53 rather increased the efficacy of the therapy. Additionally, QDN inhibited tumour growth with acceptable safety in vivo. In conclusion, QDN induced Apoptosis via triggering p53/DRP1-mediated mitochondrial fission in NSCLC cells.

QiDongNing; apoptosis; lung cancer; mitochondrial fission; p53.